JPS56125310A - Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin - Google Patents

Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin

Info

Publication number
JPS56125310A
JPS56125310A JP2862680A JP2862680A JPS56125310A JP S56125310 A JPS56125310 A JP S56125310A JP 2862680 A JP2862680 A JP 2862680A JP 2862680 A JP2862680 A JP 2862680A JP S56125310 A JPS56125310 A JP S56125310A
Authority
JP
Japan
Prior art keywords
plasma
specific gravity
serum albumin
protein
hdl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2862680A
Other languages
Japanese (ja)
Inventor
Yasuo Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON SEIYAKU KK
Original Assignee
NIPPON SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON SEIYAKU KK filed Critical NIPPON SEIYAKU KK
Priority to JP2862680A priority Critical patent/JPS56125310A/en
Publication of JPS56125310A publication Critical patent/JPS56125310A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PURPOSE: To obtain the titled solution useful for a patient of lipodysbolism, e.g., arterioschlerosis, etc., by treating specifically fraction IV-1 of plasma or corn by ethanol fractionation 6 method.
CONSTITUTION: Fraction IV-1 of plasma or corn by ethanol fractionation 6 method is used as a starting raw material. First by salting-out, weakly soluble protein is precipitated and removed from the raw material, and its supernatant liquid is subjected to gel filtration so that a salt used in the salting-out is removed. The filtrate is treated with an ionizing medium to remove the residual existing protein and concentrated, to give a protein solution consisting essentially of lipoptrotein (HDL for short) of plasm with high specific gravity and serum albumin. Lipoprotein with low specific gravity, a kind of plasma protein, sends cholesterol from blood to the wall of blood vessel, while HDL has actions to take out cholesterol from the wall of the blood vessel to blood, HDL is obtained readily as a mixed solution of serum albumin.
COPYRIGHT: (C)1981,JPO&Japio
JP2862680A 1980-03-07 1980-03-07 Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin Pending JPS56125310A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2862680A JPS56125310A (en) 1980-03-07 1980-03-07 Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2862680A JPS56125310A (en) 1980-03-07 1980-03-07 Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin

Publications (1)

Publication Number Publication Date
JPS56125310A true JPS56125310A (en) 1981-10-01

Family

ID=12253758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2862680A Pending JPS56125310A (en) 1980-03-07 1980-03-07 Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin

Country Status (1)

Country Link
JP (1) JPS56125310A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121219A (en) * 1982-01-11 1983-07-19 Green Cross Corp:The Production of human blood coagulation eighth factor
WO1990015617A1 (en) * 1989-06-15 1990-12-27 The Green Cross Corporation Albumin preparation and method of producing the same
KR100244792B1 (en) * 1997-03-21 2000-02-15 김길환 Method for recovery of immunoglublin
CN109568271A (en) * 2019-01-04 2019-04-05 徐州医科大学 A kind of rHDL of the cancer target of pH sensitivity, preparation method and application

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121219A (en) * 1982-01-11 1983-07-19 Green Cross Corp:The Production of human blood coagulation eighth factor
WO1990015617A1 (en) * 1989-06-15 1990-12-27 The Green Cross Corporation Albumin preparation and method of producing the same
KR100244792B1 (en) * 1997-03-21 2000-02-15 김길환 Method for recovery of immunoglublin
CN109568271A (en) * 2019-01-04 2019-04-05 徐州医科大学 A kind of rHDL of the cancer target of pH sensitivity, preparation method and application

Similar Documents

Publication Publication Date Title
DE3265898D1 (en) Process for the industrial preparation of collagenous materials from human placental tissues; human collagenous materials obtained and their use in biomaterials
DE3787445D1 (en) Process for the isolation of long-chain nucleic acid.
ZA89813B (en) Method for treating renal diseases
EP0399572A3 (en) Apparatus for separating proteins from blood plasma
MC1998A1 (en) COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIBLE DISEASES AND METHOD OF PREPARATION
JPS55132957A (en) Blood coagulation accelerating vessel
JPS56125310A (en) Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin
EP0136518A3 (en) Process for the purification of aqueous distillation residues obtained during the treatment of liquids in the preparation of cellulose ethers
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
DE3160632D1 (en) 4-alkylsubstituted-3-hydroxy-2-pyrroline-2,5-dione compounds for use in the prevention and treatment of kidney and bladder stones, process for preparing them and pharmaceutical composition containing them
EP0237427A3 (en) Frozen yeasts in fluid free-flowing particles, process for obtaining them and use of these yeasts in frozen doughs
JPS51118820A (en) A process for preparing heat stable macroglobulin
CA1028948A (en) Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained
GB2044071B (en) Method for separating the flesh of nuts or kernels into fibre and liquid fractions
DE3173450D1 (en) Process for the preparation of lipoprotein solutions from residues obtained from the dilipidation of blood plasma and serum, products thus obtained and their applications
DE3361689D1 (en) Process for the separation and purification of proteases and antiproteases of blood coagulation and of the protease-antiprotease complex
JPS53115660A (en) Method for treating juice
JPS5795918A (en) Purification of immunoglobulin
SU1042752A1 (en) Method of treating chronic urethritis
JPS53103974A (en) Preparatorily treating method for liquid containing protein
EP0381142A3 (en) Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
JPS5735521A (en) Fractionation of plasma protein
JPS56100723A (en) Low-modified immunoglobulin for intravenous injection and its preparation
JPS54118998A (en) Processing method of radioactive material contained liquid
JPS523271A (en) Cleaning apparatus for processed parts